For the quarter ended September 2024, Molina (MOH) reported revenue of $10.34 billion, up 21% over the same period last year. EPS came in at $6.01, compared to $5.05 in the year-ago quarter.The reported revenue represents a surprise of +3.80% over the Zacks Consensus Estimate of $9.96 billion. With the consensus EPS estimate being $5.96, the EPS surprise was +0.84%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectat ...

Molina (MOH) came out with quarterly earnings of $6.01 per share, beating the Zacks Consensus Estimate of $5.96 per share. This compares to earnings of $5.05 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 0.84%. A quarter ago, it was expected that this provider of Medicaid-related services would post earnings of $5.73 per share when it actually produced earnings of $5.86, delivering a surprise of 2.27%.Over the last four quar ...

Revenue and Membership Growth - Premium revenue for Q3 2024 was $9.7 billion, an 18% increase year-over-year[2][3] - The company served approximately 5.6 million members as of September 30, 2024, an 8% increase year-over-year[2] - Full-year 2024 premium revenue guidance remains unchanged at approximately $38 billion, a 17% increase from 2023[10] - Total membership increased to 5,598,000 in Q3 2024 from 4,995,000 in Q4 2023, with Medicaid membership reaching 4,941,000[24] - Premium revenue for Medicaid in Q3 2024 was $7,668 million, with a medical margin of $730 million and an MCR of 90.5%[25] - Consolidated premium revenue for Q3 2024 was $9,694 million, with a medical margin of $1,051 million and an MCR of 89.2%[25] Net Income and Earnings Per Share - GAAP net income for Q3 2024 was $5.65 per diluted share, a 34% increase year-over-year[2][4] - Adjusted net income for Q3 2024 was $6.01 per diluted share, a 19% increase year-over-year[2][4] - Full-year 2024 adjusted earnings per diluted share guidance remains unchanged at least $23.50, representing 13% growth over 2023[10] - Net income for Q3 2024 was $928 million, up from $875 million in Q3 2023[22] - GAAP Net income for 2024 is $326 million, or $5.65 per diluted share, compared to $245 million, or $4.21 per diluted share in 2023[33] - Adjusted net income for 2024 is $347 million, or $6.01 per diluted share, compared to $294 million, or $5.05 per diluted share in 2023[33] - 2024 guidance projects GAAP Net income of $1.25 billion, or $21.59 per diluted share[35] - Adjusted net income for 2024 is projected at $1.36 billion, or $23.50 per diluted share[35] Medical Care Ratio and Cost Management - The consolidated Medical Care Ratio (MCR) for Q3 2024 was 89.2%, reflecting focus on managing medical costs[5] - The G&A ratio for Q3 2024 was 6.5%, reflecting disciplined cost management and one-time credits[7] - Days in Claims Payable decreased to 48 days in Q3 2024 from 51 days in Q3 2023[28] - Medical claims and benefits payable ending balance was $4,732 million in Q3 2024, up from $4,204 million in Q4 2023[29] Cash Flow and Financial Position - Cash and investments at the parent company were $195 million as of September 30, 2024, down from $742 million at the end of 2023[8] - Operating cash flow for the nine months ended September 30, 2024 was $868 million, compared to $2,352 million for the same period in 2023[9] - Net cash provided by operating activities was $868 million in Q3 2024, down from $2,352 million in Q3 2023[22] - Total liabilities increased to $10,988 million in Q3 2024 from $10,677 million in Q4 2023[20] - Total stockholders' equity increased to $4,770 million in Q3 2024 from $4,215 million in Q4 2023[20] Non-GAAP Measures and Adjustments - Adjusted net income and adjusted after-tax margin are used as non-GAAP measures to assess financial performance[31][32] - Total adjustments for 2024 include $21 million for amortization of intangible assets, $11 million for acquisition-related expenses, and $(7) million for other adjustments[33] - The nine months ended September 30, 2024, include non-recurring litigation and one-time termination benefits, totaling $16 million[33] - Adjustments for 2024 guidance include $148 million for amortization of intangible assets, acquisition-related expenses, and other adjustments[35] - The income tax effect for 2024 guidance is calculated at a statutory tax rate of approximately 25.5%, resulting in a $38 million adjustment[35]

In its upcoming report, Molina (MOH) is predicted by Wall Street analysts to post quarterly earnings of $5.96 per share, reflecting an increase of 18% compared to the same period last year. Revenues are forecasted to be $9.96 billion, representing a year-over-year increase of 16.5%.The consensus EPS estimate for the quarter has been revised 1.1% higher over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during th ...

Molina Healthcare, Inc. (MOH) is set to report third-quarter 2024 results on Oct. 23, 2024, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter's earnings is currently pegged at $5.96 per share on revenues of $9.96 billion. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. The third-quarter earnings estimate has witnessed downward revisions over the past 60 days. However, the bottom-line projection indicates a year-over-year increase of 18%. The Zacks ...

Author of the Macro Trends & Inflection Points Newsletter. I spent 5 years as a co-founder and hedge fund CIO / manager. Before that, I was a hedge fund analyst/portfolio manager at a leading Canadian alternative asset manager. I write articles as part of my own due diligence on the stocks that I find interesting.Follow my twitter or substack for my thoughts on the macro trends. Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Molina (MOH) reports results for the quarter ended September 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates. The earnings report, which is expected to be released on October 23, 2024, might help the stock move higher if these key numbers are better than expe ...

Molina Healthcare, Inc. (MOH) , a multi-state managed care company, continues to benefit on the back of growing premiums, contract wins, acquisitions and a sound financial position. A solid 2024 earnings per share outlook also reinforces investors' confidence in the stock. The company's shares have gained 15.4% in the past three months, outpacing the industry and S&P 500 Composite's growth of 14.6% and 2.6%, respectively. MOH stock is currently trading at $355.15, well below its 52-week high of $423.92, sug ...

A month has gone by since the last earnings report for Molina (MOH) . Shares have added about 6.1% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Molina due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers. Molina Healthcare Q2 Earnings Beat on Growing Membership Molina ...

Molina Healthcare, Inc. (MOH) benefits on the back of growing premiums, contract wins, acquisitions and a sound financial position. A solid 2024 earnings per share outlook also reinforces investors' confidence in the stock. Zacks Rank & Price Performance Molina Healthcare currently carries a Zacks Rank #3 (Hold). The stock has gained 20.9% in the past month compared with the industry's 3.5% growth. The Zacks Medical sector has rallied 2.6% while the S&P 500 composite dipped 0.6% in the same time frame. Imag ...